HCM
HUTCHMED DRC
NASDAQ: HCM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.36
-1.69% today
Updated 2026-04-29
Market cap
$2.30B
P/E ratio
5.04
P/S ratio
4.19x
EPS (TTM)
$2.65
Dividend yield
—
52W range
$13 – $20
Volume
0.0M
HUTCHMED DRC (HCM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
83.30%
Operating margin
-13.20%
ROE
45.30%
ROA
-1.62%
Debt/equity
0.08x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $50.43M | $-9.61M | 57.72% | -10.67% | -19.05% |
| 2007 | $65.11M | $-17.19M | 57.52% | -14.93% | -26.40% |
| 2008 | $86.97M | $-17.76M | 58.46% | -16.36% | -20.41% |
| 2009 | $111.00M | $-8.75M | 59.83% | -4.16% | -7.88% |
| 2010 | $134.51M | $-6.86M | 59.38% | -1.64% | -5.10% |
| 2011 | $165.03M | $710223.00 | 55.21% | 2.49% | 0.43% |
| 2012 | $22.37M | $3.64M | 42.98% | -77.95% | 16.27% |
| 2013 | $45.97M | $5.92M | 51.69% | -2.26% | 12.87% |
| 2014 | $87.33M | $-32.82M | 32.61% | -20.88% | -37.58% |
| 2015 | $178.20M | $7.99M | 37.84% | -5.48% | 4.49% |
| 2016 | $216.08M | $11.70M | 27.65% | -21.61% | 5.41% |
| 2017 | $241.20M | $-26.74M | 27.11% | -22.15% | -11.08% |
| 2018 | $214.11M | $-74.81M | 32.77% | -43.27% | -34.94% |
| 2019 | $204.89M | $-106.02M | 21.84% | -74.57% | -51.75% |
| 2020 | $227.98M | $-125.73M | 17.31% | -87.12% | -55.15% |
| 2021 | $356.13M | $-194.65M | 27.49% | -92.19% | -54.66% |
| 2022 | $426.41M | $-360.83M | 27.04% | -96.10% | -84.62% |
| 2023 | $838.00M | $100.78M | 54.12% | 2.19% | 12.03% |
| 2024 | $630.20M | $37.73M | 44.64% | -6.94% | 5.99% |
| 2025 | $549.96M | $458.12M | 38.68% | -9.95% | 83.30% |